Private Capital Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,090
Closed -$208K 91
2019
Q3
$208K Buy
+2,090
New +$199K 0.06% 85
2019
Q2
Sell
-2,140
Closed -$202K 101
2019
Q1
$202K Buy
+2,140
New +$187K 0.06% 93
2018
Q1
Sell
-2,090
Closed -$218K 110
2017
Q4
$218K Sell
2,090
-13,661
-87% -$1.54M 0.08% 97
2017
Q3
$2.3M Buy
15,751
+231
+1% +$31.5K 0.78% 38
2017
Q2
$2.02M Buy
15,520
+470
+3% +$57.6K 0.65% 42
2017
Q1
$1.87M Buy
15,050
+50
+0.3% +$5.98K 0.61% 45
2016
Q4
$1.74M Hold
15,000
0.59% 48
2016
Q3
$1.57M Hold
15,000
0.56% 48
2016
Q2
$1.48M Hold
15,000
0.56% 46
2016
Q1
$1.5M Hold
15,000
0.67% 46
2015
Q4
$1.8M Hold
15,000
0.78% 45
2015
Q3
$1.62M Hold
15,000
0.68% 50
2015
Q2
$1.74M Hold
15,000
0.57% 58
2015
Q1
$1.73M Sell
15,000
-8,887
-37% -$1.06M 0.63% 51
2014
Q4
$2.67M Buy
23,887
+8,887
+59% +$937K 1.01% 47
2014
Q3
$1.42M Buy
15,000
+7,500
+100% +$677K 0.46% 65
2014
Q2
$644K Sell
7,500
-7,500
-50% -$570K 0.21% 79
2014
Q1
$1.05M Sell
15,000
-18,000
-55% -$1.43M 0.4% 65
2013
Q4
$2.79M Sell
33,000
-9,900
-23% -$783K 0.95% 47
2013
Q3
$3.31M Buy
42,900
+27,900
+186% +$1.96M 1.2% 40
2013
Q2
$877K Buy
+15,000
New +$903K 0.33% 75

Other funds holding CELG

Private Capital Advisors's CELG Position: Q4 2019 in Review

Private Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,090 shares — an estimated $208K sold.

Private Capital Advisors first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $3.31M in Q3 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Private Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Private Capital Advisors sold 2,090 Celgene Corp shares in Q4 2019, an estimated $208K.
  • Private Capital Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Private Capital Advisors's Celgene Corp position peaked at $3.31M in Q3 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Private Capital Advisors's 13F filing for Q4 2019, filed 9 Jan 2020.